Sound Shore Management Inc. CT Invests $68.85 Million in CVS Health Co. (NYSE:CVS)

Sound Shore Management Inc. CT purchased a new position in CVS Health Co. (NYSE:CVSFree Report) in the second quarter, HoldingsChannel.com reports. The institutional investor purchased 1,165,831 shares of the pharmacy operator’s stock, valued at approximately $68,854,000. CVS Health makes up about 2.3% of Sound Shore Management Inc. CT’s portfolio, making the stock its 28th largest holding.

A number of other large investors have also recently made changes to their positions in CVS. Gryphon Financial Partners LLC boosted its holdings in CVS Health by 48.3% during the 4th quarter. Gryphon Financial Partners LLC now owns 8,151 shares of the pharmacy operator’s stock valued at $654,000 after acquiring an additional 2,653 shares during the period. Allstate Corp grew its stake in CVS Health by 13.3% in the 4th quarter. Allstate Corp now owns 4,207 shares of the pharmacy operator’s stock worth $332,000 after acquiring an additional 493 shares in the last quarter. US Bancorp DE raised its stake in shares of CVS Health by 3.2% during the fourth quarter. US Bancorp DE now owns 991,437 shares of the pharmacy operator’s stock valued at $78,284,000 after acquiring an additional 31,027 shares in the last quarter. FineMark National Bank & Trust boosted its holdings in shares of CVS Health by 2.4% in the fourth quarter. FineMark National Bank & Trust now owns 21,461 shares of the pharmacy operator’s stock valued at $1,695,000 after purchasing an additional 505 shares during the period. Finally, TCW Group Inc. bought a new stake in CVS Health during the 4th quarter valued at $1,605,000. 80.66% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research firms have recently issued reports on CVS. Baird R W upgraded shares of CVS Health to a “hold” rating in a research note on Thursday, May 30th. Wells Fargo & Company lifted their price target on CVS Health from $60.00 to $61.00 and gave the company an “equal weight” rating in a report on Monday, August 12th. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $62.00 price objective on shares of CVS Health in a research report on Monday, September 16th. Evercore ISI decreased their price target on shares of CVS Health from $65.00 to $62.00 and set an “outperform” rating for the company in a research report on Thursday, August 8th. Finally, Robert W. Baird assumed coverage on shares of CVS Health in a research note on Thursday, May 30th. They set a “neutral” rating and a $61.00 price objective for the company. Eleven equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. According to MarketBeat, CVS Health currently has an average rating of “Moderate Buy” and a consensus target price of $72.10.

Check Out Our Latest Analysis on CVS

CVS Health Stock Performance

CVS opened at $57.51 on Friday. The stock has a market cap of $72.20 billion, a P/E ratio of 10.11, a P/E/G ratio of 0.79 and a beta of 0.53. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.86 and a quick ratio of 0.66. The firm has a fifty day moving average price of $58.31 and a 200 day moving average price of $62.60. CVS Health Co. has a 1 year low of $52.77 and a 1 year high of $83.25.

CVS Health (NYSE:CVSGet Free Report) last posted its earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.73 by $0.10. CVS Health had a net margin of 1.98% and a return on equity of 12.72%. The business had revenue of $91.23 billion for the quarter, compared to analyst estimates of $91.41 billion. During the same period in the prior year, the company posted $2.21 EPS. The company’s revenue for the quarter was up 2.6% on a year-over-year basis. Equities research analysts anticipate that CVS Health Co. will post 6.51 earnings per share for the current year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 1st. Shareholders of record on Monday, October 21st will be issued a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 4.63%. The ex-dividend date is Monday, October 21st. CVS Health’s payout ratio is 46.75%.

CVS Health Company Profile

(Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

See Also

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVSFree Report).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.